Shen CL, Wang Z. Shenqi Yiwei decoction for treatment of atrophic gastritis of spleen-stomach deficiency cold type: Clinical efficacy and influence on TXB
2 and 6-keto-PGF1α.
Shijie Huaren Xiaohua Zazhi 2018;
26:236-242. [DOI:
10.11569/wcjd.v26.i4.236]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM
To evaluate the clinical efficacy of Shenqi Yiwei decoction in the treatment of atrophic gastritis of spleen-stomach deficiency cold type and investigate its influence on TXB2 and 6-keto-PGF1α.
METHODS
Eighty-six patients with atrophic gastritis of spleen-stomach deficiency cold type were selected from January 2016 to October 2017 at the Third Affiliated Hospital of Zhejiang Chinese Medicine University, and the patients were randomly divided into either an experimental group (n = 43) or a control group (n = 43). The control group was treated with omeprazole, while the experimental group was treated with Shenqi Yiwei decoction. The patients in both groups were treated for 8 wk. The effective rates of the two groups were compared. Main symptom scores (including abdominal distension, dry mouth, anorexia, fatigue, and indigestion), endoscopic scores (including mucosal appearance, mucosal erosion, bile reflux, mucous folds, and blood vessels), TXB2 and 6-keto-PGF1α, and complications were also compared between the two groups.
RESULTS
The total effective rate was significantly higher in the experimental group than in the control group (95.35% vs 81.40%, χ2 = 4.0741, P = 0.0436). Before treatment, abdominal distension, dry mouth, anorexia, fatigue, and indigestion scores were not statistically significant between the two groups (P > 0.05); after treatment, these scored significantly decreased in both groups (P < 0.05), and the decrease was more significant in the experimental group. Before treatment, scores of mucosal appearance, mucosal erosion, bile reflux, mucous folds, and blood vessels were not statistically significant between the two groups (P > 0.05); after treatment, these scores were significantly improved in both groups (P < 0.05), and the improvement was more significant in the experimental group (P < 0.05). Before treatment, TXB2 and 6-keto-PGF1α differed significantly between the two groups (P > 0.05); after treatment, TXB2 decreased significantly and 6-keto-PGF1α increased significantly in both groups (P < 0.05), and the changes were more significant in the experimental group (P < 0.05). Adverse reactions such as constipation and vomiting did not occur in either group.
CONCLUSION
Shenqi Yiwei decoction has a good therapeutic effect in atrophic gastritis of spleen-stomach deficiency cold type, and it can significantly reduce clinical symptoms and improve endoscopic changes possibly by regulating TXB2 and 6-keto-PGF1α.
Collapse